APA (7th ed.) Citation

Schuler, E., & Nolte, F. (2016). Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5). Leukemia, 30(7), . https://doi.org/10.1038/leu.2015.340

Chicago Style (17th ed.) Citation

Schuler, Esther, and Florian Nolte. "Results of a Multicenter Prospective Phase II Trial Investigating the Safety and Efficacy of Lenalidomide in Patients with Myelodysplastic Syndromes with Isolated Del(5q) (LE-MON 5)." Leukemia 30, no. 7 (2016). https://doi.org/10.1038/leu.2015.340.

MLA (9th ed.) Citation

Schuler, Esther, and Florian Nolte. "Results of a Multicenter Prospective Phase II Trial Investigating the Safety and Efficacy of Lenalidomide in Patients with Myelodysplastic Syndromes with Isolated Del(5q) (LE-MON 5)." Leukemia, vol. 30, no. 7, 2016, https://doi.org/10.1038/leu.2015.340.